Location History:
- Jiangsu, CN (2016)
- Nanjing, CN (2014 - 2019)
Company Filing History:
Years Active: 2014-2019
Title: Shibao Yang: Innovator in Medicinal Chemistry
Introduction
Shibao Yang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for serious neurological and cardiovascular conditions. With a total of three patents to his name, Yang's work is characterized by innovative approaches to drug formulation and therapeutic applications.
Latest Patents
One of Yang's latest patents focuses on the use of a composition for preparing a medicament for the treatment of amyotrophic lateral sclerosis (ALS). This invention involves a composition that includes 3-methyl-1-phenyl-2-pyrazoline-5-one or its pharmaceutically acceptable salts, along with borneol. The medicament aims to delay the onset of ALS, extend survival time, and improve memory function in affected individuals.
Another significant patent by Yang involves 1,4-dihydro-naphthyridine derivatives and their pharmaceutical compositions. These derivatives are designed to inhibit acetylcholinesterase activity and prevent calcium influx into cells, showcasing dual activity that is crucial for treating cardiovascular diseases, cerebrovascular diseases, and dementia.
Career Highlights
Shibao Yang has worked with prominent companies in the pharmaceutical industry, including Jiangsu Simcere Pharmaceutical Research and Development Co., Ltd and Jiangsu Simcere Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to the advancement of drug development and innovation in medicinal chemistry.
Collaborations
Yang has collaborated with notable colleagues in his field, including Xiaojin Yin and Xiaoqiang Li. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Shibao Yang's contributions to medicinal chemistry through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work in developing treatments for ALS and other serious conditions highlights the importance of research and innovation in the pharmaceutical industry.